Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-18

Clinical Trial Update: A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial, sponsored by Novo Nordisk, evaluated an insulin infusion pump for the treatment of Type 2 diabetes and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED